Skip to main content
SpringerLink
Log in

Alpha-2 Adrenergic Receptor Agonists

  • Chapter
  • First Online:
Adverse Cutaneous Drug Reactions to Cardiovascular Drugs

  • 896 Accesses

Abstract

Alpha-2 adrenergic receptor agonists include clonidine, guanfacine, guanabenz, methyldopa, rilmenidine, and moxonidine. These are centrally active antihypertensive drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Breckenridge A, Dollery CT, Worlledge SM, Holborow EJ, Johnson GD. Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet. 1967;2:1265–7.

    Article  CAS  PubMed  Google Scholar 

  2. Nordstrom DM, West SG, Rubin RL. Methyldopa-induced systemic lupus erythematosus. Arthritis Rheum. 1989;32:205–8.

    Article  CAS  PubMed  Google Scholar 

  3. Dupont A, Six R. Lupus-like syndrome induced by methyldopa. Br Med J (Clin Res Ed). 1982;285:693–4.

    Article  CAS  Google Scholar 

  4. Harrington TM, Davis DE. Systemic lupus-like syndrome induced by methyldopa therapy. Chest. 1981;79:696–7.

    Article  CAS  PubMed  Google Scholar 

  5. Sherman JD, Love DE, Harrington JF. Anemia, positive lupus and rheumatoid factors with methyldopa. A report of three cases. Arch Intern Med. 1967;120:321–6.

    Article  CAS  PubMed  Google Scholar 

  6. Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev. 2002;10:337–48.

    Article  PubMed  Google Scholar 

  7. Mota AV, Vasconcelos C, Correia TM, Barros MA, Mesquita-Guimaraes J. Rilmenidine-induced photosensitivity reaction. Photodermatol Photoimmunol Photomed. 1998;14:132–3.

    Article  CAS  PubMed  Google Scholar 

  8. Vaillant L, Le Marchand D, Grognard C, Hocine R, Lorette G. Photosensitivity to methyldopa. Arch Dermatol. 1988;124:326–7.

    Article  CAS  PubMed  Google Scholar 

  9. Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M. Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2942–9.

    Article  CAS  PubMed  Google Scholar 

  10. Burry JN, Kirk J. Letter: Lichenoid drug reaction from methyldopa. Br J Dermatol. 1974;91:475–6.

    Article  CAS  PubMed  Google Scholar 

  11. Burry JN. Ulcerative lichenoid eruption from methyldopa. Arch Dermatol. 1976;112:880.

    Article  CAS  PubMed  Google Scholar 

  12. Holt PJ, Navaratnam A. Lichenoid eruption due to methyldopa. Br Med J. 1974;3:234.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Stevenson CJ. Lichenoid eruptions due to methyldopa. Br J Dermatol. 1971;85:600.

    Article  CAS  PubMed  Google Scholar 

  14. Hay KD, Reade PC. Methyldopa as a cause of oral mucous membrane reactions. Br Dent J. 1978;145:195–203.

    Article  CAS  PubMed  Google Scholar 

  15. Gonzalez JG, Marcus MD, Cruz DJ. Giant cell lichenoid dermatitis. J Am Acad Dermatol. 1986;15:87–92.

    Article  CAS  PubMed  Google Scholar 

  16. Heid E, Samsoen M, Juillard J, Eberst E, Foussereau J. Papulo-vesicular endogenous eruptions induced by methyldopa and clofibrate. Ann Dermatol Venereol. 1977;104:494–6.

    CAS  PubMed  Google Scholar 

  17. Church R. Eczema provoked by methyl dopa. Br J Dermatol. 1974;91:373–8.

    Article  CAS  PubMed  Google Scholar 

  18. van Joost T, Faber WR, Manuel HR. Drug-induced anogenital cicatricial pemphigoid. Br J Dermatol. 1980;102:715–8.

    Article  PubMed  Google Scholar 

  19. Wilkin J. Exacerbation of psoriasis during clonidine therapy. Arch Dermatol. 1981;117:4.

    Article  CAS  PubMed  Google Scholar 

  20. Prisant LM. Transdermal clonidine skin reactions. J Clin Hypertens (Greenwich). 2002;4:136–8.

    Article  Google Scholar 

  21. Crivellaro MA, Bonadonna P, Dama A, Senna G, Passalacqua G. Skin reactions to clonidine: not just a local problem. Case report. Allergol Immunopathol (Madr). 1999;27:318–9.

    CAS  Google Scholar 

  22. Doe N, Seth S, Hebert LA. Skin depigmentation related to transdermal clonidine therapy. Arch Intern Med. 1995;155:2129.

    Article  CAS  PubMed  Google Scholar 

  23. Wiser TH, Kazakis AM, LaCivita CL. Transdermal clonidine: an association with recurrent herpes simplex and hyperpigmentation. J Am Acad Dermatol. 1987;17:143–4.

    Article  CAS  PubMed  Google Scholar 

  24. Litt JZ. Drug eruption reference manual. 19th ed. Boca Raton: CRC Press (Taylor and Francis Group); 2013.

    Google Scholar 

  25. Torpet LA, Kragelund C, Reibel J, Nauntofte B. Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med. 2004;15:28–46.

    Article  PubMed  Google Scholar 

  26. Wolf R, Tamir A, Werbin N, Brenner S. Methyldopa hypersensitivity syndrome. Ann Allergy. 1993;71:166–8.

    CAS  PubMed  Google Scholar 

  27. Brody HJ, Cohen M. Black tongue secondary to methyldopa therapy. Cutis. 1986;38:187–8.

    CAS  PubMed  Google Scholar 

  28. Wells JD, Kurtay M, Lochner JC, George WL. Letter: Granulomatous skin lesions and alpha-methyldopa. Ann Intern Med. 1974;81:701–2.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Venereology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey

    Esen Özkaya & Kurtuluş Didem Yazganoğlu

Authors
  1. Esen Özkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurtuluş Didem Yazganoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Özkaya, E., Yazganoğlu, K.D. (2014). Alpha-2 Adrenergic Receptor Agonists. In: Adverse Cutaneous Drug Reactions to Cardiovascular Drugs. Springer, London. https://doi.org/10.1007/978-1-4471-6536-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6536-1_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6535-4

  • Online ISBN: 978-1-4471-6536-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation